Godfrey Phillips Share Price: ₹2,283 | 1.8% Dividend | vs ITC | Sin Stock Worth It?
Godfrey Phillips at ₹2,283 (down 42% from peak). High tobacco exposure, regulatory risks, but strong margins. Complete analysis vs ITC, dividend outlook, sin stock dilemma.
Disclaimer
This article is for educational purposes only and should not be construed as financial advice. Please consult with a certified financial advisor before making any investment decisions. Read our complete Financial Disclaimer.
Godfrey Phillips Share Price: The Sin Stock Nobody Talks About
Here's a company most investors ignore.
Not because it's unprofitable. Not because it's small. But because it sells cigarettes.
Godfrey Phillips India - the company that makes Marlboro cigarettes in India under license from Philip Morris. Also owns Four Square, Red & White, and Cavender's.
February 2026, stock is trading at ₹2,283. Down a brutal 42% from its all-time high of ₹3,947 hit just 4 months ago in October 2025.
The crash? Government slapped a new excise duty structure on cigarettes effective February 1, 2026. The stock tanked 19% in two weeks according to Business Standard.
Here's the uncomfortable truth: This company makes ₹346 crore in market cap selling a product that kills people. High margins (because addiction), high dividends (because cash generation), but also high regulatory risk (because sin tax).
The question: Is Godfrey Phillips a value trap or a contrarian opportunity?
Let me break it down like I'm analyzing it with my own money on the line. No sugarcoating the tobacco elephant in the room.
Current Stock Status (February 19, 2026)
Current Price: ₹2,283 (IndMoney data) 52-Week High: ₹3,947 (Oct 2025) 52-Week Low: ₹1,650.80 Market Cap: ₹34,659 crore P/E Ratio: ~31 (expensive for a tobacco stock) Dividend Yield: 1.79% (₹41 per share latest dividend)
Recent performance:
- Down 42% from peak (₹3,947 to ₹2,283)
- 1 year return: Mixed (volatility from tax changes)
- Post-tax announcement (Feb 1): Down 19%
Translation: This stock has been hammered. Investors fleeing sin stocks after government tightened the noose.
But here's the twist - the business is actually doing fine. Q3 FY26 results were solid.
What is Godfrey Phillips? (Beyond the Cigarettes)
Primary business: Manufacturing and distributing cigarettes (75%+ of revenue) Brands owned:
- Marlboro (under Philip Morris license - this is the cash cow)
- Four Square
- Red & White
- Cavender's
- Tipper
Other businesses:
- 24Seven retail chain (convenience stores - think mini 7-Elevens)
- Tea business (small segment)
- Pan masala (Modi Paan - non-tobacco segment they're trying to grow)
Promoter holding: 72.6% (Modi family - not related to PM Modi, different surname spelling)
Founded: 1936 (88 years old - British legacy company) Headquarters: Delhi
The business model is simple:
- Buy tobacco from farmers/auctions
- Manufacture cigarettes at factories (Rabale, Ghaziabad)
- Distribute through massive pan-India network
- Collect fat margins (because nicotine addiction = pricing power)
Why it's profitable: Unlike most FMCG, tobacco customers don't switch brands easily. A Marlboro smoker stays a Marlboro smoker. This creates incredible pricing power and brand loyalty.
Why it's risky: Government can destroy your economics overnight with one tax notification. Which just happened.
Q3 FY26 Results: The Numbers Behind the Crash
Let me show you what actually happened in October-December 2025 quarter (before the tax bomb):
The Hard Data
| Metric | Q3 FY26 | Q3 FY25 | Growth |
|---|---|---|---|
| Total Income | ₹1,817 cr | ₹1,583 cr | +14.8% |
| Net Profit | ₹343 cr | ₹316 cr | +8.7% |
| EBITDA Margin | ~28-30% | ~27-28% | Expansion |
| Revenue Growth | +14.8% | - | Strong |
Source: 5paisa Q3 results
Q1 FY26 was even better:
- Gross Sales: ₹4,094 cr (up 32.6% YoY)
- EBITDA: ₹338 cr (up 25.2%)
- PAT: ₹356 cr (up whopping 55.9%)
Wait, so profits are growing double-digit, but stock crashed 42%?
Yes. Because markets don't care about last quarter. They care about next 5 years.
And next 5 years look uncertain with this new tax regime.
What the Tax Change Actually Means
Old regime: GST compensation cess based on cigarette length New regime (Feb 1, 2026): Additional excise duty of ₹2,050 to ₹8,500 per 1,000 cigarettes
Translation: Government squeezed manufacturers. Either:
- Absorb the tax (margins shrink from 30% to 22-25%)
- Pass it to consumers (prices go up 15-20%, volumes drop)
- Mix of both (margin hit + volume hit)
What Godfrey Phillips did: Raised prices on Marlboro by ₹15-20 per pack in February.
The gamble: Will smokers pay ₹200 for a pack instead of ₹180? Or will they downgrade to cheaper brands (Four Square) or worse - quit?
Early signals (February 2026): According to Business Standard analysis, volumes are holding up better than feared. Smokers are paying up. But it's too early to call.
The ITC Comparison: David vs Goliath
Everyone compares Godfrey Phillips to ITC. Let's settle this.
| Metric | Godfrey Phillips | ITC |
|---|---|---|
| Market Cap | ₹34,659 cr | ₹5.13 lakh cr |
| Revenue (FY25) | ~₹5,000-6,000 cr | ₹70,000+ cr |
| Cigarette Market Share | 15-18% | 75%+ |
| Diversification | Minimal (85% tobacco) | High (FMCG 45%, Hotels, Paperboards) |
| Premium Brand | Marlboro (licensed) | Classic, Gold Flake (owned) |
| Recent Stock Fall | -19% (2 weeks post-tax) | -10% (same period) |
| P/E Ratio | ~31 | ~25 |
| Dividend Yield | 1.79% | ~2.5-3% |
Source: Alpha Spread comparison
Why Godfrey Phillips Fell Harder
ITC is protected by diversification. When cigarette margins shrink, ITC still has:
- FMCG business (Aashirvaad, Sunfeast, Bingo) growing 60% in Q3 according to Business Standard
- Hotels (profitable, growing post-COVID)
- Paperboards (steady cash cow)
Godfrey Phillips is 85% tobacco. When cigarettes hurt, the whole company bleeds.
The Marlboro Advantage (And Disadvantage)
Godfrey Phillips' secret weapon: Marlboro brand license from Philip Morris International.
Why it's powerful:
- Marlboro is world's #1 cigarette brand
- Indian smokers see it as premium, aspirational
- Higher pricing power than local brands
But here's the catch: Godfrey Phillips doesn't own Marlboro. They pay royalty to Philip Morris.
What this means:
- When taxes increase, they can't just eat the margin hit easily (royalty is fixed %)
- If Philip Morris ever pulls the license (unlikely but possible), Godfrey is in trouble
ITC owns their brands outright (Classic, Gold Flake, Navy Cut). No royalty leak.
Market Share Dynamics
According to TradeBrains analysis, Godfrey Phillips actually positioned better than ITC for this tax shock. How?
Strategic positioning:
- Focused on urban/semi-urban markets where premium pricing sticks
- Launched cheaper Marlboro variants (Marlboro Compact, Marlboro Fine Touch) before tax hike
- Brand loyalty higher (Marlboro smokers won't easily switch to Four Square)
ITC's challenge:
- Massive scale means harder to be nimble
- Portfolio includes cheaper cigarettes (Navy Cut, Scissors) where consumers are more price-sensitive
The irony: Smaller Godfrey Phillips might navigate this crisis better than giant ITC because they're focused on premium addicted smokers who'll pay up.
Market Cap Growth Comparison
Let's zoom out 5 years:
Godfrey Phillips market cap:
- March 2021: ₹4,744 crore
- March 2025: ₹35,162 crore
- CAGR: 49.27% (yes, nearly 50% annually!)
ITC market cap:
- March 2021: ₹2,68,948 crore
- March 2025: ₹5,12,828 crore
- CAGR: 13.78%
Source: Search results comparison data
Wait, Godfrey Phillips crushed ITC in returns?
Yes. And this is the sin stock paradox. The higher the regulatory risk, the higher the returns (when things go well). But also higher the crash when government strikes (which just happened).
The Sin Stock Dilemma: Ethics vs Returns
Let me address the elephant: Should you own tobacco stocks?
I'm not going to preach. I'll just lay out both sides.
The "No" Case (Why Many Avoid)
1. ESG Concerns
- Tobacco kills 13 lakh Indians annually (government data)
- Secondhand smoke harms kids, families
- Your profits = someone's cancer treatment bills
2. Regulatory Guillotine
- Government can destroy economics anytime (Feb 2026 proof)
- Future bans possible (flavored cigarettes already banned)
- Tax increases unpredictable
3. Declining Category
- Youth smoking rates dropping (health awareness)
- Vaping/e-cigarettes could disrupt (though banned in India currently)
- Demographic headwind (Gen Z less likely to smoke than Boomers)
4. Moral Licensing
- "I donate to charity" doesn't offset "I profit from addiction"
- Can't unsee that your dividend came from someone's lung disease
The "Yes" Case (Why Some Invest Anyway)
1. Spectacular Returns
- Godfrey Phillips: 49% CAGR (2021-2025)
- Philip Morris globally: Outperformed S&P 500 over 30 years
- Math doesn't care about morality
2. Addiction = Pricing Power
- Cigarette demand is inelastic (addicts pay any price)
- Margins stable even through recessions
- Cash generation exceptional (28-30% EBITDA)
3. Legal Product
- Government allows it, taxes it, profits from it (excise duty)
- If ethical issue, why doesn't government ban it? (Because they need the tax revenue)
- "I'm not forcing anyone to smoke"
4. Diversification Play
- Tobacco stocks zig when tech zags
- Defensive during market crashes (addicts smoke even in recession)
- Portfolio hedge
5. Transition Argument
- "I'll invest now while it's profitable, exit when regulations tighten"
- Capital allocation problem: Earn 30% here, donate 10% to lung cancer research?
My Personal Take
I don't own Godfrey Phillips. Not because of pure ethics - I own alcohol stocks (which also harms people).
I avoid it because regulatory risk is coin-flip. One notification from government = 40% crash. I can't model that risk.
But I understand why others own it: The returns are undeniable. And the "sin" aspect is priced in (that's why P/E is 31 despite growing business).
If you're considering buying, ask yourself:
- Can I sleep at night owning tobacco? (Honest answer)
- Can I stomach 40% crashes when government strikes?
- Is the 20-30% potential return worth the guilt/risk?
No judgment either way. Just know what you're buying into.
Valuation: Expensive, Fair, or Cheap?
P/E Ratio: 31
Let's put this in context.
Compare with Peers
| Company | P/E Ratio | Business | Risk Level |
|---|---|---|---|
| Godfrey Phillips | 31 | Pure tobacco play | Extremely high |
| ITC | 25 | Diversified (tobacco 40%) | Medium |
| VST Industries | 22 | Pure tobacco | High |
| HUL | 58 | FMCG (soaps, shampoo) | Low |
| Titan | 75 | Jewelry/watches | Medium |
Godfrey Phillips at P/E 31 is expensive compared to tobacco peers (ITC 25, VST 22).
Why the premium?
- Marlboro brand power (premium positioning)
- Growth trajectory (55% profit growth in Q1 FY26)
- Market expects recovery post-tax panic
But is it justified? Hard to say. If earnings drop 20% in FY27 due to tax impact, forward P/E is actually 38-40 (very expensive).
Dividend Analysis: Not the Cash Cow You'd Expect
Current dividend yield: 1.79%
Wait, tobacco stock paying less than 2% yield? That's surprising.
Compare with:
- ITC: 2.5-3% yield
- VST Industries: 4-5% yield
- Coal India: 5-6% yield
Why is Godfrey Phillips dividend low?
Hypothesis 1: They're reinvesting profits into 24Seven retail expansion (capex heavy) Hypothesis 2: Promoters (Modi family at 72.6% holding) prefer capital appreciation over dividends (tax efficiency) Hypothesis 3: They're building cash buffer for regulatory uncertainties
Dividend history:
- FY26 (YTD): ₹77 total declared
- Next dividend: ₹20/share (ex-date Aug 24, 2026, payment Sep 9, 2026)
Source: IndMoney dividend data
For income investors: Godfrey Phillips disappoints. ITC is better dividend play.
For growth investors: The low payout ratio (25-30%) means more capital for growth. Could pay off if 24Seven becomes meaningful.
DCF Quickcheck: What's Fair Value?
Let me do napkin math:
Current earnings: ~₹1,200-1,400 crore annually (FY26 estimate) Market cap: ₹34,659 crore P/E: 31 implies ₹1,118 crore profit (rough)
Bear case (tax impact continues):
- Earnings drop 15% to ₹1,000 crore
- Market re-rates to P/E 22 (tobacco average)
- Fair value: ₹22,000 crore market cap = ₹1,450/share
- Downside: 36% from ₹2,283
Base case (business adapts):
- Earnings stable at ₹1,200 crore
- P/E 25 (ITC parity)
- Fair value: ₹30,000 crore = ₹1,975/share
- Downside: 13% from ₹2,283
Bull case (premiumization wins):
- Earnings grow 10% to ₹1,500 crore
- P/E 28 (Marlboro premium justified)
- Fair value: ₹42,000 crore = ₹2,763/share
- Upside: 21% from ₹2,283
My take: At ₹2,283, stock is fairly valued to slightly expensive. Not a screaming buy, but not insanely overpriced either.
Attractive entry: ₹1,800-2,000 (if it falls another 15-20%) Sell zone: Above ₹3,200 (P/E 35+ is unjustifiable for tobacco)
Risks: What Could Go Very Wrong
Risk 1: Another Tax Increase (Highest Probability)
What just happened in February 2026 can happen again.
Government loves sin taxes because:
- Easy revenue (people won't riot over cigarette taxes like they would over petrol)
- Politically popular ("we're discouraging smoking")
- Meets WHO commitments (tobacco control)
Historical pattern:
- 2017: GST on cigarettes (28% + cess)
- 2020: No relief during COVID (unlike other sectors)
- 2026: Additional excise duty
Next trigger could be:
- 2027 Budget (another ₹2,000/1000 sticks)
- WHO pressure (India is signatory to tobacco control treaty)
- State-level taxes (Maharashtra, Delhi could add local cess)
Probability: 60-70% in next 3 years
Impact: Stock could fall another 20-30% if announced
Risk 2: Marlboro License Loss (Low Probability, High Impact)
What if Philip Morris pulls the Marlboro license?
Why they might:
- ESG pressure on Philip Morris globally
- India becomes too regulatory-risky for brand association
- Royalty disputes
Impact on Godfrey Phillips:
- Lose 50-60% of premium cigarette revenue
- Forced to push Four Square, Red & White (lower margins)
- Stock crashes 50-60%
Probability: 10-15% (low, but not zero)
Why it's unlikely: Philip Morris makes good royalty income from India without capital investment. Why kill golden goose?
Risk 3: Volume Collapse (Medium Probability)
Cigarette consumption in India is declining.
Reasons:
- Health awareness (especially urban educated youth)
- Price increases (₹200/pack pushes people to beedis or quitting)
- Vaping alternatives (currently banned, but could be legalized)
Historical volume trend:
- 2015-2020: Flat to slight decline
- 2021-2023: Recovery post-COVID
- 2024-2026: Stagnant (price increases offsetting volume)
Worst case: If volumes drop 5% annually for 5 years while prices increase only 3%, real revenue shrinks.
Probability: 40-50%
Godfrey Phillips defense:
- Premium Marlboro segment is sticky (addicts don't quit easily)
- Downtrading from ITC's premium to Godfrey's mid-range (potential share gain)
Risk 4: 24Seven Retail Distraction
Godfrey Phillips is trying to diversify into retail (24Seven convenience stores).
The problem: Retail is cutthroat low-margin business. Amazon, Reliance, DMart are giants.
What if:
- 24Seven burns cash (loses ₹100-200 crore/year)
- Distracts management from core tobacco business
- Never reaches profitability (like many retail startups)
This would be value destruction. Tobacco profits subsidizing retail losses.
Probability: 30-40% that 24Seven becomes a drag
Watch metric: If 24Seven doesn't turn profitable by FY28, management should shut it down. If they keep burning cash, red flag.
Should You Buy Godfrey Phillips at ₹2,283?
Here's my honest framework.
BUY if:
1. You're Okay with Sin Stock Exposure
- No ethical qualms about tobacco profits
- Can stomach the ESG criticism
2. You're a Contrarian
- Stock down 42% from peak
- Everyone hates tobacco right now (that's when bargains appear)
- Tax panic might be overdone
3. You Believe in Marlboro Premium
- Urban smokers will pay ₹200/pack
- Brand loyalty trumps price sensitivity
- Godfrey positioned better than ITC for premiumization
4. You Want Concentrated Bet
- Not looking for diversification (ITC is better for that)
- Want pure tobacco exposure
- Willing to ride volatility
My buy price: ₹1,800-2,100 (wait for 15-20% further dip)
HOLD if:
1. You Bought Below ₹1,500
- You're up 50%+
- Let winners run (despite recent crash)
2. You're Long-Term (10+ Years)
- Tobacco won't disappear overnight
- Addicts keep smoking through thick and thin
- Dividends will eventually compound
3. You're Hedging Portfolio
- Tobacco zigs when tech zags
- Defensive play
SELL if:
1. You Bought Near Peak (₹3,500-3,900)
- Down 40%+ already
- Cut losses, redeploy to better opportunities
- Tax loss harvesting (book loss for tax benefit)
2. You Can't Handle Regulatory Risk
- Every budget announcement gives you anxiety
- You keep checking "will government ban tobacco" news
- Sleep more valuable than returns
3. ESG Matters to You
- Your values changed
- "Profit from addiction" guilt is real
- Move to ITC (more diversified, less guilt)
4. You See Better Opportunities
- Banking stocks at low P/E (SBI at 12 P/E)
- IT stocks crashed 30% (TCS, Infosys)
- Pharma export recovery play
My sell trigger: If Godfrey Phillips breaks below ₹1,600 (52-week low area), something structurally broken. Exit.
My Personal Decision
I'm staying away - not because of ethics alone, but risk-reward doesn't excite me at ₹2,283.
Why:
- P/E 31 is expensive for regulatory risk
- Dividend yield 1.79% doesn't compensate for volatility
- Can't model when next tax will hit
- 24Seven distraction worries me
But I respect the bull case: If you bought at ₹1,000-1,500 in 2021-22, you're up 100-150%. That's life-changing money. Sin stocks work - until they don't.
For most investors: Skip Godfrey Phillips. Buy ITC if you want tobacco exposure (diversification buffers risk).
For contrarians with strong stomach: Wait for ₹1,800-2,000, then buy small position (5% of portfolio max).
Frequently Asked Questions
Is Godfrey Phillips a good stock to buy in 2026?
At ₹2,283 (down 42% from peak), Godfrey Phillips is a high-risk, high-reward play. Recent excise duty hike creates near-term uncertainty, but Q3 results showed 14.8% revenue growth and 8.7% profit growth. Good for contrarian investors comfortable with sin stocks and regulatory risk. Not suitable for conservative portfolios or ESG-focused investors. Better entry point would be ₹1,800-2,000. ITC offers similar tobacco exposure with lower risk due to diversification.
What is Godfrey Phillips vs ITC - which is better?
ITC is safer due to diversification (FMCG, hotels, paperboards cushion tobacco risk), larger scale (75% market share vs Godfrey's 15%), and higher dividend yield (2.5-3% vs 1.8%). Godfrey Phillips offers higher growth potential (49% market cap CAGR 2021-2025 vs ITC's 14%), Marlboro brand premium, and better positioning for urban premiumization. For conservative investors: choose ITC. For aggressive contrarians betting on premium cigarette demand: Godfrey Phillips. Or own both (70% ITC, 30% Godfrey) for balanced tobacco exposure.
Will Godfrey Phillips survive new tobacco tax 2026?
Yes, Godfrey Phillips will survive. The company already raised prices ₹15-20/pack in February 2026 to offset excise duty increase. Q3 FY26 showed strong fundamentals (₹343 crore profit, 28-30% margins). Marlboro's premium positioning means smokers are less price-sensitive than mass-market brands. However, expect margin compression from 30% to 25-27% and potential volume pressure. Stock crashed 19% post-tax announcement but business resilience intact. Survival isn't question - profitability level is.
What is Godfrey Phillips target price 2026?
Analyst targets vary widely due to tax uncertainty. Conservative target: ₹1,975-2,100 (P/E 25, 13% downside risk). Base case: ₹2,400-2,600 (P/E 27, 10% upside). Bull case: ₹2,800-3,000 (P/E 30 if premiumization succeeds, 30% upside). Much depends on Q4 FY26 and Q1 FY27 results showing volume resilience post-price hike. Fair value range: ₹2,000-2,500. Above ₹3,200 is expensive. Below ₹1,800 is attractive entry for risk-takers.
Should I invest in Godfrey Phillips or VST Industries?
Godfrey Phillips: Marlboro brand power, 49% CAGR (2021-25), urban focus, but expensive at P/E 31 and low dividend 1.8%. VST Industries: Charms brand, regional strength (South India), cheaper P/E 22, higher dividend 4-5%, but slower growth. For growth: Godfrey Phillips (if willing to pay premium). For income: VST Industries (better yield). For safety: ITC (diversification). Godfrey has higher upside but also higher downside risk. VST is steadier but boring. Both face identical regulatory risks.
Is Godfrey Phillips ethical to invest in?
This is personal decision. Cons: Tobacco kills 13 lakh Indians annually, profits from addiction, secondhand smoke harms families. Government itself calls it "sin tax." ESG funds exclude tobacco entirely. Pros: Legal product, government profits from excise duty, adults' personal choice, dividends can be donated to healthcare. Many legendary investors (Warren Buffett historically) owned tobacco for returns despite ethics. Question to ask yourself: Can I sleep at night knowing my returns come from cigarettes? If answer is no, skip it. If yes, acknowledge the trade-off.
What happens if government bans cigarettes in India?
Outright ban is extremely unlikely because government collects ₹60,000+ crore annually in tobacco taxes (excise + GST). Banning would create massive black market (like alcohol prohibition failed). More realistic risks: incremental tax increases every 2-3 years, stricter advertising bans, plain packaging mandates, flavor bans. Godfrey Phillips would survive these but with margin pressure. If hypothetical total ban happened, company would pivot to 24Seven retail (currently small segment) and tea business, but 85% of revenue would evaporate. Stock would crash 80-90%. Probability of total ban in next 10 years: Under 5%.
How does Godfrey Phillips make money from Marlboro?
Godfrey Phillips manufactures and sells Marlboro in India under exclusive license from Philip Morris International (PMI). They pay royalty to PMI (percentage of sales, exact % not publicly disclosed, likely 3-5%). Arrangement benefits both: PMI gets India revenue without capital investment or regulatory risk, Godfrey gets world's #1 cigarette brand. Risk: License could theoretically be terminated, though unlikely since it's profitable for PMI. Marlboro accounts for roughly 50-60% of Godfrey's cigarette revenue and drives premium positioning vs ITC's local brands.
My Final Take: High Risk, High Reward - But Mostly Risk
Let me be blunt: Godfrey Phillips is not for everyone.
It's for investors who:
- Have strong stomach for 40% crashes
- Don't lose sleep over "sin stock" label
- Believe premium smokers will keep paying up
- Can afford to lose this allocation completely
The bull case works if:
- Marlboro addicts prove price-inelastic (early signs positive)
- No more tax increases for 2-3 years (questionable assumption)
- 24Seven retail becomes profitable (long shot)
- Urban premiumization trend continues
Total return potential: 15-20% annually (if all goes well)
The bear case triggers if:
- Another tax hike in 2027 Budget
- Volumes collapse 5-10% as smokers quit
- Philip Morris pulls license (black swan)
- 24Seven bleeds cash indefinitely
Downside risk: -40 to -60% (we've already seen -42% in 4 months)
My rating: 6/10 - Decent business, scary regulatory environment, expensive valuation.
What I'd do with ₹1 lakh:
Option A: Skip Godfrey Phillips entirely, buy ₹70k ITC + ₹30k HUL (safer FMCG play)
Option B: Wait for ₹1,800-1,900, then put ₹30k in Godfrey (small contrarian bet), rest in index fund
Option C: If you must buy now at ₹2,283, limit to ₹20-25k maximum (5% of portfolio), treat it as lottery ticket
I'd choose Option A. The juice isn't worth the squeeze for me.
But if you bought at ₹1,200 in 2022, congratulations - you doubled your money even after the crash. That's the sin stock magic (and curse).
For more stock analysis frameworks, check our TCS IT sector breakdown and BHEL PSU analysis.
To understand systematic investing approach, read our SIP guide.
For a deep dive into value investing principles and how behavioral biases affect stock selection — highly relevant when evaluating contrarian plays like Godfrey Phillips — Value Investing and Behavioral Finance by Parag Parikh is one of the most insightful books written specifically for the Indian market context.
Disclaimer: This article is for educational purposes only and not investment advice. Godfrey Phillips India is a publicly listed company; all data is from public sources. Stock markets are subject to risk, including loss of principal. Tobacco stocks carry additional regulatory and ethical risks. The author does not own Godfrey Phillips shares (disclosed for transparency). Past performance (49% CAGR 2021-2025) doesn't guarantee future returns. Tax impact projections are speculative. Please consult a SEBI-registered investment advisor before making investment decisions. Opinions expressed are personal views based on analysis of public data. This is not a recommendation to buy, hold, or sell.
Sources:
- IndMoney - Godfrey Phillips Share Price
- TickerTape - Godfrey Phillips Stock Data
- Business Standard - ITC Godfrey Tax Impact
- TradeBrains - Why Godfrey Phillips Could Emerge Stronger
- Business Standard - Cigarette Tax Impact on ITC and Godfrey
- 5paisa - Godfrey Phillips Quarterly Results
- Screener - Godfrey Phillips Fundamentals
- IndMoney - Godfrey Phillips Dividend History